Skip to main content
SpringerLink
Log in

Bayer critiques study of long-term mortality of aprotinin

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Bayer.Bayer Responds to study and commentary published in Journal of American Medical Association (JAMA). Media Release: 6 Feb 2007. Available from: URL: http://www.bayer.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bayer critiques study of long-term mortality of aprotinin. React. Wkly. 1140, 4 (2007). https://doi.org/10.2165/00128415-200711400-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711400-00012

Keywords

Search

Navigation